They allow organizations to break down industry-wide data silos and share data with research partners while maximizing compliance and confidentiality. With the right mindset and implementation, this tech could unlock enormous value for healthcare R&D. The post Data Clean Rooms: The Secret to Secure Healthcare Data Sharing appeared first on MedCity News.
Caroline Connor’s concerns about her son’s development began around his 1st birthday, when she noticed he wasn’t talking or using any words. Their pediatrician didn’t seem worried, but the speech delay persisted. At 2½, Mason was diagnosed with autism. The Connors went on a mission, searching for anything that would help. “We just started researching…
The weight loss market is at yet another inflection point. The euphoria of the past three years is now confronting the realities of how obesity medications will scale to address an epidemic that impacts over 1 billion people globally. The post The Weight Loss Market in 2026: 3 Questions That Will Shape the Next Decade…
HHS Secretary Robert F. Kennedy Jr. is reportedly planning to dismiss all 16 members of the U.S. Preventive Services Task Force, a panel that decides which preventive care services are fully covered by payers. This has sparked concern from healthcare leaders who warn it could undermine access to important cancer screenings, as well as vital…
Abarca Health and LucyRx plan to combine to build a larger independent PBM serving more than 9 million members. The post Abarca Health and LucyRx to Combine to Scale Independent PBM Model appeared first on MedCity News.
This issue brief provides an overview of the decennial census and discusses potential implications of the changes outlined in a September 2026 proposed rule to prohibit the collection of race and ethnicity data on the census and exclude many noncitizen immigrants from the apportionment count.
Matching the right patient to the right therapy now requires understanding what’s driving the apnea, not just how often it occurs. Closing that gap means rethinking what sleep apnea testing identifies and where it happens. The post Why the Next Era of Sleep Medicine Depends on Better Diagnostics appeared first on MedCity News.
Ionis Pharmaceuticals’ Tryngolza is now the first approved therapy for treating severe hypertriglyceridemia, a prevalent chronic metabolic disorder that can lead to acute pancreatitis. This drug is a key piece of Ionis’s pivot away from partnering its assets, and instead developing and commercializing them on its own. The post A Metabolic Disease Posing Severe Pancreatic…
The in-depth, constantly-changing birds-eye view of disease that computational models provide is an essential next step in linking our ever-expanding clinical knowledge and data with drug development. The post From Trial-and-Error to Targeted Success: How Computational Disease Models Can Help Patients and Pharma Companies appeared first on MedCity News.
That is the title of a new publication with co-authors Joshua T. Cohen, Louis P. Garrison, Dana A. Goldman, Jalpa A. Doshi, Joshua Krieger, Darius N. Lakdawalla, Peter J. Neumann, Charles E. Phelps, Melanie D. Whittington and Richard Willke. This consensus paper aims to provide researchers with a user guide for estimating broader societal value…